A phase II study of triapine for advanced adenocarcinoma of the pancreas

Trial Profile

A phase II study of triapine for advanced adenocarcinoma of the pancreas

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Oct 2013

At a glance

  • Drugs OCX 191 (Primary)
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Dec 2012 Planned number of patients changed from 48 to 116 as reported by ClinicalTrials.gov record.
    • 11 Jan 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top